-
1
-
-
0032721181
-
Randomized, double-blind, placebo-controlled, multicentered trial of the efficacy of a single dose of live oral cholera vaccine CVD 103-HgR in preventing cholera following challenge with Vibrio cholerae O1 El tor inaba three months after vaccination
-
Tacket C.O., Cohen M.B., Wasserman S.S., Losonsky G., Livio S., Kotloff K., et al. Randomized, double-blind, placebo-controlled, multicentered trial of the efficacy of a single dose of live oral cholera vaccine CVD 103-HgR in preventing cholera following challenge with Vibrio cholerae O1 El tor inaba three months after vaccination. Infect Immun 1999, 67(December (12)):6341-6345.
-
(1999)
Infect Immun
, vol.67
, Issue.DECEMBER 12
, pp. 6341-6345
-
-
Tacket, C.O.1
Cohen, M.B.2
Wasserman, S.S.3
Losonsky, G.4
Livio, S.5
Kotloff, K.6
-
2
-
-
77749314807
-
So similar, yet so different: uncovering distinctive features in the genomes of Salmonella enterica serovars typhimurium and typhi
-
Sabbagh S.C., Forest C.G., Lepage C., Leclerc J.M., Daigle F. So similar, yet so different: uncovering distinctive features in the genomes of Salmonella enterica serovars typhimurium and typhi. FEMS Microbiol Lett 2010, 305(April (1)):1-13.
-
(2010)
FEMS Microbiol Lett
, vol.305
, Issue.APRIL 1
, pp. 1-13
-
-
Sabbagh, S.C.1
Forest, C.G.2
Lepage, C.3
Leclerc, J.M.4
Daigle, F.5
-
3
-
-
37349110158
-
Salmonellae interplay with host cells
-
Haraga A., Ohlson M.B., Miller S.I. Salmonellae interplay with host cells. Nat Rev Microbiol 2008, 6(January (1)):53-66.
-
(2008)
Nat Rev Microbiol
, vol.6
, Issue.JANUARY 1
, pp. 53-66
-
-
Haraga, A.1
Ohlson, M.B.2
Miller, S.I.3
-
4
-
-
82155166368
-
Salmonella effector proteins and host-cell responses
-
Srikanth C.V., Mercado-Lubo R., Hallstrom K., McCormick B.A. Salmonella effector proteins and host-cell responses. Cell Mol Life Sci 2011, 68(November (22)):3687-3697.
-
(2011)
Cell Mol Life Sci
, vol.68
, Issue.NOVEMBER 22
, pp. 3687-3697
-
-
Srikanth, C.V.1
Mercado-Lubo, R.2
Hallstrom, K.3
McCormick, B.A.4
-
5
-
-
84860521139
-
Functions of the Salmonella pathogenicity island 2 (SPI-2) type III secretion system effectors
-
Figueira R., Holden D.W. Functions of the Salmonella pathogenicity island 2 (SPI-2) type III secretion system effectors. Microbiology 2012, 158(May (Pt 5)):1147-1161.
-
(2012)
Microbiology
, vol.158
, Issue.MAY PART 5
, pp. 1147-1161
-
-
Figueira, R.1
Holden, D.W.2
-
6
-
-
0034971522
-
Salmonella pathogenicity islands encoding type III secretion systems
-
Hansen-Wester I., Hensel M. Salmonella pathogenicity islands encoding type III secretion systems. Microbes Infect 2001, 3(June (7)):549-559.
-
(2001)
Microbes Infect
, vol.3
, Issue.JUNE 7
, pp. 549-559
-
-
Hansen-Wester, I.1
Hensel, M.2
-
7
-
-
0036089517
-
Characterization of Salmonella enterica derivatives harboring defined aroC and Salmonella pathogenicity island 2 type III secretion system (ssaV) mutations by immunization of healthy volunteers
-
Hindle Z., Chatfield S.N., Phillimore J., Bentley M., Johnson J., Cosgrove C.A., et al. Characterization of Salmonella enterica derivatives harboring defined aroC and Salmonella pathogenicity island 2 type III secretion system (ssaV) mutations by immunization of healthy volunteers. Infect Immun 2002, 70(July (7)):3457-3467.
-
(2002)
Infect Immun
, vol.70
, Issue.JULY 7
, pp. 3457-3467
-
-
Hindle, Z.1
Chatfield, S.N.2
Phillimore, J.3
Bentley, M.4
Johnson, J.5
Cosgrove, C.A.6
-
8
-
-
77950595802
-
In a randomized, double-blinded, placebo-controlled trial, the single oral dose typhoid vaccine, M01ZH09, is safe and immunogenic at doses up to 1.7×10(10) colony-forming units
-
Lyon C.E., Sadigh K.S., Carmolli M.P., Harro C., Sheldon E., Lindow J.C., et al. In a randomized, double-blinded, placebo-controlled trial, the single oral dose typhoid vaccine, M01ZH09, is safe and immunogenic at doses up to 1.7×10(10) colony-forming units. Vaccine 2010, 28(April (20)):3602-3608.
-
(2010)
Vaccine
, vol.28
, Issue.APRIL 20
, pp. 3602-3608
-
-
Lyon, C.E.1
Sadigh, K.S.2
Carmolli, M.P.3
Harro, C.4
Sheldon, E.5
Lindow, J.C.6
-
9
-
-
81355135586
-
Attenuated strains of Salmonella enterica serovars Typhi and Paratyphi as live oral vaccines against enteric fever
-
Informa Healthcare USA, New York, G. Dougan, M.F. Good, M.A. Liu, G. Nabel, J.P. Nataro, R. Rappuoli (Eds.)
-
Levine M.M., Galen J.E., Pasetti M.F., Sztein M.B. Attenuated strains of Salmonella enterica serovars Typhi and Paratyphi as live oral vaccines against enteric fever. New generation vaccines 2010, 497-505. Informa Healthcare USA, New York. 4th ed. G. Dougan, M.F. Good, M.A. Liu, G. Nabel, J.P. Nataro, R. Rappuoli (Eds.).
-
(2010)
New generation vaccines
, pp. 497-505
-
-
Levine, M.M.1
Galen, J.E.2
Pasetti, M.F.3
Sztein, M.B.4
-
10
-
-
0033985811
-
Phase I clinical trials of aroA aroD and aroA aroD htrA attenuated S. typhi vaccines: effect of formulation on safety and immunogenicity
-
Dilts D.A., Riesenfeld-Orn I., Fulginiti J.P., Ekwall E., Granert C., Nonenmacher J., et al. Phase I clinical trials of aroA aroD and aroA aroD htrA attenuated S. typhi vaccines: effect of formulation on safety and immunogenicity. Vaccine 2000, 18(February (15)):1473-1484.
-
(2000)
Vaccine
, vol.18
, Issue.FEBRUARY 15
, pp. 1473-1484
-
-
Dilts, D.A.1
Riesenfeld-Orn, I.2
Fulginiti, J.P.3
Ekwall, E.4
Granert, C.5
Nonenmacher, J.6
-
11
-
-
0023113672
-
Safety, infectivity, immunogenicity, and in vivo stability of two attenuated auxotrophic mutant strains of Salmonella typhi, 541Ty and 543Ty, as live oral vaccines in humans
-
Levine M.M., Herrington D., Murphy J.R., Morris J.G., Losonsky G., Tall B., et al. Safety, infectivity, immunogenicity, and in vivo stability of two attenuated auxotrophic mutant strains of Salmonella typhi, 541Ty and 543Ty, as live oral vaccines in humans. J Clin Invest 1987, 79(March (3)):888-902.
-
(1987)
J Clin Invest
, vol.79
, Issue.MARCH 3
, pp. 888-902
-
-
Levine, M.M.1
Herrington, D.2
Murphy, J.R.3
Morris, J.G.4
Losonsky, G.5
Tall, B.6
-
12
-
-
0030028340
-
Evaluation of a phoP/phoQ-deleted, aroA-deleted live oral Salmonella typhi vaccine strain in human volunteers
-
Hohmann E.L., Oletta C.A., Miller S.I. Evaluation of a phoP/phoQ-deleted, aroA-deleted live oral Salmonella typhi vaccine strain in human volunteers. Vaccine 1996, 14(1):19-24.
-
(1996)
Vaccine
, vol.14
, Issue.1
, pp. 19-24
-
-
Hohmann, E.L.1
Oletta, C.A.2
Miller, S.I.3
-
13
-
-
0029799771
-
PhoP/phoQ-deleted Salmonella typhi (Ty800) is a safe and immunogenic single-dose typhoid fever vaccine in volunteers
-
Hohmann E.L., Oletta C.A., Killeen K.P., Miller S.I. phoP/phoQ-deleted Salmonella typhi (Ty800) is a safe and immunogenic single-dose typhoid fever vaccine in volunteers. J Infect Dis 1996, 173(6):1408-1414.
-
(1996)
J Infect Dis
, vol.173
, Issue.6
, pp. 1408-1414
-
-
Hohmann, E.L.1
Oletta, C.A.2
Killeen, K.P.3
Miller, S.I.4
-
14
-
-
80855127613
-
Effect of deletion of genes involved in lipopolysaccharide core and O-antigen synthesis on virulence and immunogenicity of Salmonella enterica serovar typhimurium
-
Kong Q., Yang J., Liu Q., Alamuri P., Roland K.L., Curtiss R. Effect of deletion of genes involved in lipopolysaccharide core and O-antigen synthesis on virulence and immunogenicity of Salmonella enterica serovar typhimurium. Infect Immun 2011, 79(October (10)):4227-4239.
-
(2011)
Infect Immun
, vol.79
, Issue.OCTOBER 10
, pp. 4227-4239
-
-
Kong, Q.1
Yang, J.2
Liu, Q.3
Alamuri, P.4
Roland, K.L.5
Curtiss, R.6
-
15
-
-
33645214751
-
Altering the length of the lipopolysaccharide O antigen has an impact on the interaction of Salmonella enterica serovar typhimurium with macrophages and complement
-
Murray G.L., Attridge S.R., Morona R. Altering the length of the lipopolysaccharide O antigen has an impact on the interaction of Salmonella enterica serovar typhimurium with macrophages and complement. J Bacteriol 2006, 188(April (7)):2735-2739.
-
(2006)
J Bacteriol
, vol.188
, Issue.APRIL 7
, pp. 2735-2739
-
-
Murray, G.L.1
Attridge, S.R.2
Morona, R.3
-
16
-
-
84891628571
-
Structural diversity in Salmonella O antigens and its genetic basis
-
Liu B., Knirel Y.A., Feng L., Perepelov A.V., Senchenkova S.N., Reeves P.R., et al. Structural diversity in Salmonella O antigens and its genetic basis. FEMS Microbiol Rev 2013 July, 10.1111/1574-6976.12034.
-
(2013)
FEMS Microbiol Rev
-
-
Liu, B.1
Knirel, Y.A.2
Feng, L.3
Perepelov, A.V.4
Senchenkova, S.N.5
Reeves, P.R.6
-
17
-
-
67649386535
-
Essential roles of hydrophobic residues in both MD-2 and toll-like receptor 4 in activation by endotoxin
-
Resman N., Vasl J., Oblak A., Pristovsek P., Gioannini T.L., Weiss J.P., et al. Essential roles of hydrophobic residues in both MD-2 and toll-like receptor 4 in activation by endotoxin. J Biol Chem 2009, 284(May (22)):15052-15060.
-
(2009)
J Biol Chem
, vol.284
, Issue.MAY 22
, pp. 15052-15060
-
-
Resman, N.1
Vasl, J.2
Oblak, A.3
Pristovsek, P.4
Gioannini, T.L.5
Weiss, J.P.6
-
18
-
-
77950591965
-
MD-2-mediated ionic interactions between lipid A and TLR4 are essential for receptor activation
-
Meng J., Lien E., Golenbock D.T. MD-2-mediated ionic interactions between lipid A and TLR4 are essential for receptor activation. J Biol Chem 2010, 285(March (12)):8695-8702.
-
(2010)
J Biol Chem
, vol.285
, Issue.MARCH 12
, pp. 8695-8702
-
-
Meng, J.1
Lien, E.2
Golenbock, D.T.3
-
19
-
-
84867596085
-
Phosphate groups of lipid A are essential for Salmonella enterica serovar typhimurium virulence and affect innate and adaptive immunity
-
Kong Q., Six D.A., Liu Q., Gu L., Wang S., Alamuri P., et al. Phosphate groups of lipid A are essential for Salmonella enterica serovar typhimurium virulence and affect innate and adaptive immunity. Infect Immun 2012, 80(September (9)):3215-3224.
-
(2012)
Infect Immun
, vol.80
, Issue.SEPTEMBER 9
, pp. 3215-3224
-
-
Kong, Q.1
Six, D.A.2
Liu, Q.3
Gu, L.4
Wang, S.5
Alamuri, P.6
-
20
-
-
79953231573
-
A live attenuated strain of Yersinia pestis KIM as a vaccine against plague
-
Sun W., Six D., Kuang X., Roland K.L., Raetz C.R., Curtiss R. A live attenuated strain of Yersinia pestis KIM as a vaccine against plague. Vaccine 2011, 29(April (16)):2986-2998.
-
(2011)
Vaccine
, vol.29
, Issue.APRIL 16
, pp. 2986-2998
-
-
Sun, W.1
Six, D.2
Kuang, X.3
Roland, K.L.4
Raetz, C.R.5
Curtiss, R.6
-
21
-
-
84875498824
-
Pathogenicity of Yersinia pestis synthesis of 1-dephosphorylated lipid A
-
Sun W., Six D.A., Reynolds C.M., Chung H.S., Raetz C.R., Curtiss R. Pathogenicity of Yersinia pestis synthesis of 1-dephosphorylated lipid A. Infect Immun 2013, 81(April (4)):1172-1185.
-
(2013)
Infect Immun
, vol.81
, Issue.APRIL 4
, pp. 1172-1185
-
-
Sun, W.1
Six, D.A.2
Reynolds, C.M.3
Chung, H.S.4
Raetz, C.R.5
Curtiss, R.6
-
22
-
-
62449178347
-
Salmonella enterica serovar typhimurium strains with regulated delayed attenuation in vivo
-
Curtiss R., Wanda S.Y., Gunn B.M., Zhang X., Tinge S.A., Ananthnarayan V., et al. Salmonella enterica serovar typhimurium strains with regulated delayed attenuation in vivo. Infect Immun 2009, 77(March (3)):1071-1082.
-
(2009)
Infect Immun
, vol.77
, Issue.MARCH 3
, pp. 1071-1082
-
-
Curtiss, R.1
Wanda, S.Y.2
Gunn, B.M.3
Zhang, X.4
Tinge, S.A.5
Ananthnarayan, V.6
-
23
-
-
77955132053
-
AraC protein, regulation of the l-arabinose operon in Escherichia coli, and the light switch mechanism of AraC action
-
Schleif R. AraC protein, regulation of the l-arabinose operon in Escherichia coli, and the light switch mechanism of AraC action. FEMS Microbiol Rev 2010, 34(September (5)):779-796.
-
(2010)
FEMS Microbiol Rev
, vol.34
, Issue.SEPTEMBER 5
, pp. 779-796
-
-
Schleif, R.1
-
24
-
-
58849132311
-
Evaluation of new generation Salmonella enterica serovar typhimurium vaccines with regulated delayed attenuation to induce immune responses against PspA
-
Li Y., Wang S., Scarpellini G., Gunn B., Xin W., Wanda S.Y., et al. Evaluation of new generation Salmonella enterica serovar typhimurium vaccines with regulated delayed attenuation to induce immune responses against PspA. Proc Natl Acad Sci U S A 2009, 106(January (2)):593-598.
-
(2009)
Proc Natl Acad Sci U S A
, vol.106
, Issue.JANUARY 2
, pp. 593-598
-
-
Li, Y.1
Wang, S.2
Scarpellini, G.3
Gunn, B.4
Xin, W.5
Wanda, S.Y.6
-
25
-
-
77955302589
-
Live recombinant Salmonella typhi vaccines constructed to investigate the role of rpoS in eliciting immunity to a heterologous antigen
-
Shi H., Santander J., Brenneman K.E., Wanda S.Y., Wang S., Senechal P., et al. Live recombinant Salmonella typhi vaccines constructed to investigate the role of rpoS in eliciting immunity to a heterologous antigen. PLoS ONE 2010, 5(June (6)):e11142.
-
(2010)
PLoS ONE
, vol.5
, Issue.JUNE 6
-
-
Shi, H.1
Santander, J.2
Brenneman, K.E.3
Wanda, S.Y.4
Wang, S.5
Senechal, P.6
-
26
-
-
84884209157
-
A phase 1 dose-escalation trial in adults of three recombinant attenuated Salmonella typhi vaccine vectors producing Streptococcus pneumoniae surface protein antigen PspA
-
Frey S.E., Lottenbach K.R., Hill H., Blevins T.P., Yu Y., Zhang Y., et al. A phase 1 dose-escalation trial in adults of three recombinant attenuated Salmonella typhi vaccine vectors producing Streptococcus pneumoniae surface protein antigen PspA. Vaccine 2013, 31(42):4874-4880.
-
(2013)
Vaccine
, vol.31
, Issue.42
, pp. 4874-4880
-
-
Frey, S.E.1
Lottenbach, K.R.2
Hill, H.3
Blevins, T.P.4
Yu, Y.5
Zhang, Y.6
-
27
-
-
84880066467
-
Attenuating gene expression (AGE) for vaccine development
-
Pascual D.W., Suo Z., Cao L., Avci R., Yang X. Attenuating gene expression (AGE) for vaccine development. Virulence 2013, 4(July (5)):384-390.
-
(2013)
Virulence
, vol.4
, Issue.JULY 5
, pp. 384-390
-
-
Pascual, D.W.1
Suo, Z.2
Cao, L.3
Avci, R.4
Yang, X.5
-
28
-
-
84867087677
-
Flagella overexpression attenuates Salmonella pathogenesis
-
Yang X., Thornburg T., Suo Z., Jun S., Robison A., Li J., et al. Flagella overexpression attenuates Salmonella pathogenesis. PLoS ONE 2012, 7(10):e46828.
-
(2012)
PLoS ONE
, vol.7
, Issue.10
-
-
Yang, X.1
Thornburg, T.2
Suo, Z.3
Jun, S.4
Robison, A.5
Li, J.6
-
29
-
-
84860445997
-
Vulnerabilities in Yersinia pestis caf operon are unveiled by a Salmonella vector
-
Cao L., Lim T., Jun S., Thornburg T., Avci R., Yang X. Vulnerabilities in Yersinia pestis caf operon are unveiled by a Salmonella vector. PLoS ONE 2012, 7(4):e36283.
-
(2012)
PLoS ONE
, vol.7
, Issue.4
-
-
Cao, L.1
Lim, T.2
Jun, S.3
Thornburg, T.4
Avci, R.5
Yang, X.6
-
30
-
-
0025110368
-
Cloning and characterization of the asd gene of Salmonella typhimurium: use in stable maintenance of recombinant plasmids in Salmonella vaccine strains
-
Galán J.E., Nakayama K., Curtiss R. Cloning and characterization of the asd gene of Salmonella typhimurium: use in stable maintenance of recombinant plasmids in Salmonella vaccine strains. Gene 1990, 94:29-35.
-
(1990)
Gene
, vol.94
, pp. 29-35
-
-
Galán, J.E.1
Nakayama, K.2
Curtiss, R.3
-
31
-
-
0000605871
-
Biosynthesis of the aromatic amino acids
-
ASM Press, Washington, DC, F.C. Neidhardt, R. Curtiss, J.L. Ingraham, E.C.C. Lin, K.B. Low, B. Magasanik (Eds.)
-
Pittard A.J. Biosynthesis of the aromatic amino acids. Escherichia coli and Salmonella: cellular and molecular biology 1996, 458-484. ASM Press, Washington, DC. 2nd ed. F.C. Neidhardt, R. Curtiss, J.L. Ingraham, E.C.C. Lin, K.B. Low, B. Magasanik (Eds.).
-
(1996)
Escherichia coli and Salmonella: cellular and molecular biology
, pp. 458-484
-
-
Pittard, A.J.1
-
32
-
-
0025602727
-
Stabilization of recombinant avirulent vaccine strains in vivo
-
Curtiss R., Galan J.E., Nakayama K., Kelly S.M. Stabilization of recombinant avirulent vaccine strains in vivo. Res Microbiol 1990, 141(September (7-8)):797-805.
-
(1990)
Res Microbiol
, vol.141
, Issue.7-8 SEPTEMBER
, pp. 797-805
-
-
Curtiss, R.1
Galan, J.E.2
Nakayama, K.3
Kelly, S.M.4
-
33
-
-
0022555837
-
Single-stranded DNA binding proteins required for DNA replication
-
Chase J.W., Williams K.R. Single-stranded DNA binding proteins required for DNA replication. Annu Rev Biochem 1986, 55:103-136.
-
(1986)
Annu Rev Biochem
, vol.55
, pp. 103-136
-
-
Chase, J.W.1
Williams, K.R.2
-
34
-
-
0028246888
-
Escherichia coli single-stranded DNA-binding protein: multiple DNA-binding modes and cooperativities
-
Lohman T.M., Ferrari M.E. Escherichia coli single-stranded DNA-binding protein: multiple DNA-binding modes and cooperativities. Annu Rev Biochem 1994, 63:527-570.
-
(1994)
Annu Rev Biochem
, vol.63
, pp. 527-570
-
-
Lohman, T.M.1
Ferrari, M.E.2
-
35
-
-
73449141130
-
A new generation of stable, nonantibiotic, low-copy-number plasmids improves immune responses to foreign antigens in Salmonella enterica serovar typhi live vectors
-
Galen J.E., Wang J.Y., Chinchilla M., Vindurampulle C., Vogel J.E., Levy H., et al. A new generation of stable, nonantibiotic, low-copy-number plasmids improves immune responses to foreign antigens in Salmonella enterica serovar typhi live vectors. Infect Immun 2010, 78(January (1)):337-347.
-
(2010)
Infect Immun
, vol.78
, Issue.JANUARY 1
, pp. 337-347
-
-
Galen, J.E.1
Wang, J.Y.2
Chinchilla, M.3
Vindurampulle, C.4
Vogel, J.E.5
Levy, H.6
-
36
-
-
84880897338
-
Novel methods for expression of foreign antigens in live vector vaccines
-
Wang J.Y., Harley R.H., Galen J.E. Novel methods for expression of foreign antigens in live vector vaccines. Hum Vaccin Immunother 2013, 9(July (7)):1558-1564.
-
(2013)
Hum Vaccin Immunother
, vol.9
, Issue.JULY 7
, pp. 1558-1564
-
-
Wang, J.Y.1
Harley, R.H.2
Galen, J.E.3
-
37
-
-
0035189087
-
+-T-cell responses
-
+-T-cell responses. Infect Immun 2001, 69(12):7493-7500.
-
(2001)
Infect Immun
, vol.69
, Issue.12
, pp. 7493-7500
-
-
Bumann, D.1
-
38
-
-
0035422682
-
Can a 'flawless' live vector vaccine strain be engineered?
-
Galen J.E., Levine M.M. Can a 'flawless' live vector vaccine strain be engineered?. Trends Microbiol 2001, 9(8):372-376.
-
(2001)
Trends Microbiol
, vol.9
, Issue.8
, pp. 372-376
-
-
Galen, J.E.1
Levine, M.M.2
-
39
-
-
68149145653
-
Salmonella enterica serovar typhi live vector vaccines finally come of age
-
Galen J.E., Pasetti M.F., Tennant S.M., Olvera-Ruiz P., Sztein M.B., Levine M.M. Salmonella enterica serovar typhi live vector vaccines finally come of age. Immunol Cell Biol 2009, 87(July (5)):400-412.
-
(2009)
Immunol Cell Biol
, vol.87
, Issue.JULY 5
, pp. 400-412
-
-
Galen, J.E.1
Pasetti, M.F.2
Tennant, S.M.3
Olvera-Ruiz, P.4
Sztein, M.B.5
Levine, M.M.6
-
40
-
-
77951004550
-
New technologies in using recombinant attenuated Salmonella vaccine vectors
-
Curtiss R., Xin W., Li Y., Kong W., Wanda S.Y., Gunn B., et al. New technologies in using recombinant attenuated Salmonella vaccine vectors. Crit Rev Immunol 2010, 30(3):255-270.
-
(2010)
Crit Rev Immunol
, vol.30
, Issue.3
, pp. 255-270
-
-
Curtiss, R.1
Xin, W.2
Li, Y.3
Kong, W.4
Wanda, S.Y.5
Gunn, B.6
-
41
-
-
36749070605
-
Improving live attenuated bacterial carriers for vaccination and therapy
-
Loessner H., Endmann A., Leschner S., Bauer H., Zelmer A., zurLage S., et al. Improving live attenuated bacterial carriers for vaccination and therapy. Int J Med Microbiol 2008, 298(January (1-2)):21-26.
-
(2008)
Int J Med Microbiol
, vol.298
, Issue.1-2 JANUARY
, pp. 21-26
-
-
Loessner, H.1
Endmann, A.2
Leschner, S.3
Bauer, H.4
Zelmer, A.5
zurLage, S.6
-
42
-
-
84555218359
-
Salmonella enterica as a vaccine carrier
-
Hegazy W.A., Hensel M. Salmonella enterica as a vaccine carrier. Future Microbiol 2012, 7(January (1)):111-127.
-
(2012)
Future Microbiol
, vol.7
, Issue.JANUARY 1
, pp. 111-127
-
-
Hegazy, W.A.1
Hensel, M.2
-
43
-
-
77956625002
-
Salmonella vaccine vectors displaying delayed antigen synthesis in vivo to enhance immunogenicity
-
Wang S., Li Y., Scarpellini G., Kong W., Shi H., Baek C.H., et al. Salmonella vaccine vectors displaying delayed antigen synthesis in vivo to enhance immunogenicity. Infect Immun 2010, 78(September (9)):3969-3980.
-
(2010)
Infect Immun
, vol.78
, Issue.SEPTEMBER 9
, pp. 3969-3980
-
-
Wang, S.1
Li, Y.2
Scarpellini, G.3
Kong, W.4
Shi, H.5
Baek, C.H.6
-
44
-
-
33846516797
-
The lactose repressor system: paradigms for regulation, allosteric behavior and protein folding
-
Wilson C.J., Zhan H., Swint-Kruse L., Matthews K.S. The lactose repressor system: paradigms for regulation, allosteric behavior and protein folding. Cell Mol Life Sci 2007, 64(January (1)):3-16.
-
(2007)
Cell Mol Life Sci
, vol.64
, Issue.JANUARY 1
, pp. 3-16
-
-
Wilson, C.J.1
Zhan, H.2
Swint-Kruse, L.3
Matthews, K.S.4
-
45
-
-
41549099248
-
The UP element is necessary but not sufficient for growth rate-dependent control of the Escherichia coli guaB promoter
-
Husnain S.I., Thomas M.S. The UP element is necessary but not sufficient for growth rate-dependent control of the Escherichia coli guaB promoter. J Bacteriol 2008, 190(April (7)):2450-2457.
-
(2008)
J Bacteriol
, vol.190
, Issue.APRIL 7
, pp. 2450-2457
-
-
Husnain, S.I.1
Thomas, M.S.2
-
46
-
-
64049118038
-
Salmonella enterica serovar typhimurium HtrA: regulation of expression and role of the chaperone and protease activities during infection
-
Lewis C., Skovierova H., Rowley G., Rezuchova B., Homerova D., Stevenson A., et al. Salmonella enterica serovar typhimurium HtrA: regulation of expression and role of the chaperone and protease activities during infection. Microbiology 2009, 155(March (Pt 3)):873-881.
-
(2009)
Microbiology
, vol.155
, Issue.MARCH PART 3
, pp. 873-881
-
-
Lewis, C.1
Skovierova, H.2
Rowley, G.3
Rezuchova, B.4
Homerova, D.5
Stevenson, A.6
-
47
-
-
0038433318
-
Immune responses dependent on antigen location in recombinant attenuated Salmonella typhimurium vaccines following oral immunization
-
Kang H.Y., Curtiss R. Immune responses dependent on antigen location in recombinant attenuated Salmonella typhimurium vaccines following oral immunization. FEMS Immunol Med Microbiol 2003, 37(July (2-3)):99-104.
-
(2003)
FEMS Immunol Med Microbiol
, vol.37
, Issue.2-3 JULY
, pp. 99-104
-
-
Kang, H.Y.1
Curtiss, R.2
-
48
-
-
9244246299
-
Adaptation of the endogenous Salmonella enterica serovar typhi clyA-encoded hemolysin for antigen export enhances the immunogenicity of anthrax protective antigen domain 4 expressed by the attenuated live-vector vaccine strain CVD 908-htrA
-
Galen J.E., Zhao L., Chinchilla M., Wang J.Y., Pasetti M.F., Green J., et al. Adaptation of the endogenous Salmonella enterica serovar typhi clyA-encoded hemolysin for antigen export enhances the immunogenicity of anthrax protective antigen domain 4 expressed by the attenuated live-vector vaccine strain CVD 908-htrA. Infect Immun 2004, 72(December (12)):7096-7106.
-
(2004)
Infect Immun
, vol.72
, Issue.DECEMBER 12
, pp. 7096-7106
-
-
Galen, J.E.1
Zhao, L.2
Chinchilla, M.3
Wang, J.Y.4
Pasetti, M.F.5
Green, J.6
-
49
-
-
58849119173
-
Mucosal immunization with attenuated Salmonella enterica serovar typhi expressing protective antigen of anthrax toxin (PA83) primes monkeys for accelerated serum antibody responses to parenteral PA83 vaccine
-
Galen J.E., Chinchilla M., Pasetti M.F., Wang J.Y., Zhao L., Arciniega-Martinez I., et al. Mucosal immunization with attenuated Salmonella enterica serovar typhi expressing protective antigen of anthrax toxin (PA83) primes monkeys for accelerated serum antibody responses to parenteral PA83 vaccine. J Infect Dis 2009, 199(February (3)):326-335.
-
(2009)
J Infect Dis
, vol.199
, Issue.FEBRUARY 3
, pp. 326-335
-
-
Galen, J.E.1
Chinchilla, M.2
Pasetti, M.F.3
Wang, J.Y.4
Zhao, L.5
Arciniega-Martinez, I.6
-
50
-
-
84868152482
-
Immunity to intracellular Salmonella depends on surface-associated antigens
-
Barat S., Willer Y., Rizos K., Claudi B., Mazé A., Schemmer A.K., et al. Immunity to intracellular Salmonella depends on surface-associated antigens. PLoS Pathog 2012, 8(10):e1002966.
-
(2012)
PLoS Pathog
, vol.8
, Issue.10
-
-
Barat, S.1
Willer, Y.2
Rizos, K.3
Claudi, B.4
Mazé, A.5
Schemmer, A.K.6
-
51
-
-
2642703408
-
Delivery of epitopes by the Salmonella type III secretion system for vaccine development
-
Russmann H., Shams H., Poblete F., Fu Y., Galan J.E., Donis R.O. Delivery of epitopes by the Salmonella type III secretion system for vaccine development. Science 1998, 281(July (5376)):565-568.
-
(1998)
Science
, vol.281
, Issue.JULY 5376
, pp. 565-568
-
-
Russmann, H.1
Shams, H.2
Poblete, F.3
Fu, Y.4
Galan, J.E.5
Donis, R.O.6
-
52
-
-
84863275571
-
Evaluation of Salmonella enterica type III secretion system effector proteins as carriers for heterologous vaccine antigens
-
Hegazy W.A., Xu X., Metelitsa L., Hensel M. Evaluation of Salmonella enterica type III secretion system effector proteins as carriers for heterologous vaccine antigens. Infect Immun 2012, 80(March (3)):1193-1202.
-
(2012)
Infect Immun
, vol.80
, Issue.MARCH 3
, pp. 1193-1202
-
-
Hegazy, W.A.1
Xu, X.2
Metelitsa, L.3
Hensel, M.4
-
53
-
-
48249135779
-
Regulated programmed lysis of recombinant Salmonella in host tissues to release protective antigens and confer biological containment
-
Kong W., Wanda S.Y., Zhang X., Bollen W., Tinge S.A., Roland K.L., et al. Regulated programmed lysis of recombinant Salmonella in host tissues to release protective antigens and confer biological containment. Proc Natl Acad Sci U S A 2008, 105(July (27)):9361-9366.
-
(2008)
Proc Natl Acad Sci U S A
, vol.105
, Issue.JULY 27
, pp. 9361-9366
-
-
Kong, W.1
Wanda, S.Y.2
Zhang, X.3
Bollen, W.4
Tinge, S.A.5
Roland, K.L.6
-
54
-
-
0028810414
-
Attenuated Shigella as a DNA delivery vehicle for DNA-mediated immunization
-
Sizemore D.R., Branstrom A.A., Sadoff J.C. Attenuated Shigella as a DNA delivery vehicle for DNA-mediated immunization. Science 1995, 270(October (5234)):299-302.
-
(1995)
Science
, vol.270
, Issue.OCTOBER 5234
, pp. 299-302
-
-
Sizemore, D.R.1
Branstrom, A.A.2
Sadoff, J.C.3
-
55
-
-
0030857449
-
Attenuated bacteria as a DNA delivery vehicle for DNA-mediated immunization
-
Sizemore D.R., Branstrom A.A., Sadoff J.C. Attenuated bacteria as a DNA delivery vehicle for DNA-mediated immunization. Vaccine 1997, 15(June (8)):804-807.
-
(1997)
Vaccine
, vol.15
, Issue.JUNE 8
, pp. 804-807
-
-
Sizemore, D.R.1
Branstrom, A.A.2
Sadoff, J.C.3
-
56
-
-
0037405146
-
Attenuated Salmonella enterica serovar typhi and Shigella flexneri 2a strains mucosally deliver DNA vaccines encoding measles virus hemagglutinin, inducing specific immune responses and protection in cotton rats
-
Pasetti M.F., Barry E.M., Losonsky G., Singh M., Medina-Moreno S.M., Polo J.M., et al. Attenuated Salmonella enterica serovar typhi and Shigella flexneri 2a strains mucosally deliver DNA vaccines encoding measles virus hemagglutinin, inducing specific immune responses and protection in cotton rats. J Virol 2003, 77(May (9)):5209-5217.
-
(2003)
J Virol
, vol.77
, Issue.MAY 9
, pp. 5209-5217
-
-
Pasetti, M.F.1
Barry, E.M.2
Losonsky, G.3
Singh, M.4
Medina-Moreno, S.M.5
Polo, J.M.6
-
57
-
-
84869786857
-
Turning self-destructing Salmonella into a universal DNA vaccine delivery platform
-
Kong W., Brovold M., Koeneman B.A., Clark-Curtiss J., Curtiss R. Turning self-destructing Salmonella into a universal DNA vaccine delivery platform. Proc Natl Acad Sci U S A 2012, 109(November (47)):19414-19419.
-
(2012)
Proc Natl Acad Sci U S A
, vol.109
, Issue.NOVEMBER 47
, pp. 19414-19419
-
-
Kong, W.1
Brovold, M.2
Koeneman, B.A.3
Clark-Curtiss, J.4
Curtiss, R.5
-
58
-
-
80855136559
-
Engineering and preclinical evaluation of attenuated nontyphoidal Salmonella strains serving as live oral vaccines and as reagent strains
-
Tennant S.M., Wang J.Y., Galen J.E., Simon R., Pasetti M.F., Gat O., et al. Engineering and preclinical evaluation of attenuated nontyphoidal Salmonella strains serving as live oral vaccines and as reagent strains. Infect Immun 2011, 79(October (10)):4175-4185.
-
(2011)
Infect Immun
, vol.79
, Issue.OCTOBER 10
, pp. 4175-4185
-
-
Tennant, S.M.1
Wang, J.Y.2
Galen, J.E.3
Simon, R.4
Pasetti, M.F.5
Gat, O.6
-
59
-
-
80855127606
-
Salmonella enterica serovar enteritidis core O polysaccharide conjugated to H:g,m flagellin as a candidate vaccine for protection against invasive infection with S. enteritidis
-
Simon R., Tennant S.M., Wang J.Y., Schmidlein P.J., Lees A., Ernst R.K., et al. Salmonella enterica serovar enteritidis core O polysaccharide conjugated to H:g,m flagellin as a candidate vaccine for protection against invasive infection with S. enteritidis. Infect Immun 2011, 79(October (10)):4240-4249.
-
(2011)
Infect Immun
, vol.79
, Issue.OCTOBER 10
, pp. 4240-4249
-
-
Simon, R.1
Tennant, S.M.2
Wang, J.Y.3
Schmidlein, P.J.4
Lees, A.5
Ernst, R.K.6
-
60
-
-
84878592756
-
Sustained protection in mice immunized with fractional doses of Salmonella enteritidis core and o polysaccharide-flagellin glycoconjugates
-
Simon R., Wang J.Y., Boyd M.A., Tulapurkar M.E., Ramachandran G., Tennant S.M., et al. Sustained protection in mice immunized with fractional doses of Salmonella enteritidis core and o polysaccharide-flagellin glycoconjugates. PLoS ONE 2013, 8(May (5)):e64680.
-
(2013)
PLoS ONE
, vol.8
, Issue.MAY 5
-
-
Simon, R.1
Wang, J.Y.2
Boyd, M.A.3
Tulapurkar, M.E.4
Ramachandran, G.5
Tennant, S.M.6
-
61
-
-
78650569511
-
A novel Salmonella typhi-based immunotherapy promotes tumor killing via an antitumor Th1-type cellular immune response and neutrophil activation in a mouse model of breast cancer
-
Vendrell A., Gravisaco M.J., Pasetti M.F., Croci M., Colombo L., Rodríguez C., et al. A novel Salmonella typhi-based immunotherapy promotes tumor killing via an antitumor Th1-type cellular immune response and neutrophil activation in a mouse model of breast cancer. Vaccine 2011, 29(January (4)):728-736.
-
(2011)
Vaccine
, vol.29
, Issue.JANUARY 4
, pp. 728-736
-
-
Vendrell, A.1
Gravisaco, M.J.2
Pasetti, M.F.3
Croci, M.4
Colombo, L.5
Rodríguez, C.6
-
62
-
-
84875304575
-
Therapeutic effects of Salmonella typhi in a mouse model of T-cell lymphoma
-
Vendrell A., Gravisaco M.J., Goin J.C., Pasetti M.F., Herschllik L., De Toro J., et al. Therapeutic effects of Salmonella typhi in a mouse model of T-cell lymphoma. J Immunother 2013, 36(April (3)):171-180.
-
(2013)
J Immunother
, vol.36
, Issue.APRIL 3
, pp. 171-180
-
-
Vendrell, A.1
Gravisaco, M.J.2
Goin, J.C.3
Pasetti, M.F.4
Herschllik, L.5
De Toro, J.6
-
63
-
-
77951218320
-
Novel cancer vaccine based on genes of Salmonella pathogenicity island 2
-
Xiong G., Husseiny M.I., Song L., Erdreich-Epstein A., Shackleford G.M., Seeger R.C., et al. Novel cancer vaccine based on genes of Salmonella pathogenicity island 2. Int J Cancer 2010, 126(June (11)):2622-2634.
-
(2010)
Int J Cancer
, vol.126
, Issue.JUNE 11
, pp. 2622-2634
-
-
Xiong, G.1
Husseiny, M.I.2
Song, L.3
Erdreich-Epstein, A.4
Shackleford, G.M.5
Seeger, R.C.6
-
64
-
-
84860862938
-
Survivin in solid tumors: rationale for development of inhibitors
-
Church D.N., Talbot D.C. Survivin in solid tumors: rationale for development of inhibitors. Curr Oncol Rep 2012, 14(April (2)):120-128.
-
(2012)
Curr Oncol Rep
, vol.14
, Issue.APRIL 2
, pp. 120-128
-
-
Church, D.N.1
Talbot, D.C.2
-
65
-
-
67349153373
-
The first clinical use of a live-attenuated Listeria monocytogenes vaccine: a phase I safety study of Lm-LLO-E7 in patients with advanced carcinoma of the cervix
-
Maciag P.C., Radulovic S., Rothman J. The first clinical use of a live-attenuated Listeria monocytogenes vaccine: a phase I safety study of Lm-LLO-E7 in patients with advanced carcinoma of the cervix. Vaccine 2009, 27(June (30)):3975-3983.
-
(2009)
Vaccine
, vol.27
, Issue.JUNE 30
, pp. 3975-3983
-
-
Maciag, P.C.1
Radulovic, S.2
Rothman, J.3
-
66
-
-
84863258367
-
Lm-LLO-based immunotherapies and HPV-associated disease
-
Wallecha A., French C., Petit R., Singh R., Amin A., Rothman J. Lm-LLO-based immunotherapies and HPV-associated disease. J Oncol 2012, 2012:542851.
-
(2012)
J Oncol
, vol.2012
, pp. 542851
-
-
Wallecha, A.1
French, C.2
Petit, R.3
Singh, R.4
Amin, A.5
Rothman, J.6
-
67
-
-
0035576230
-
Two Listeria monocytogenes vaccine vectors that express different molecular forms of human papilloma virus-16 (HPV-16) E7 induce qualitatively different T cell immunity that correlates with their ability to induce regression of established tumors immortalized by HPV-16
-
Gunn G.R., Zubair A., Peters C., Pan Z.K., Wu T.C., Paterson Y. Two Listeria monocytogenes vaccine vectors that express different molecular forms of human papilloma virus-16 (HPV-16) E7 induce qualitatively different T cell immunity that correlates with their ability to induce regression of established tumors immortalized by HPV-16. J Immunol 2001, 167(December (11)):6471-6479.
-
(2001)
J Immunol
, vol.167
, Issue.DECEMBER 11
, pp. 6471-6479
-
-
Gunn, G.R.1
Zubair, A.2
Peters, C.3
Pan, Z.K.4
Wu, T.C.5
Paterson, Y.6
|